Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

被引：0

作者：

William W. Tseng

Carol J. Swallow

Dirk C. Strauss

Sylvie Bonvalot

Piotr Rutkowski

Samuel J. Ford

Ricardo J. Gonzalez

Rebecca A. Gladdy

David E. Gyorki

Mark Fairweather

Kyo Won Lee

Markus Albertsmeier

Winan J. van Houdt

Magalie Fau

Carolyn Nessim

Giovanni Grignani

Kenneth Cardona

Vittorio Quagliuolo

Valerie Grignol

Jeffrey M. Farma

Elisabetta Pennacchioli

Marco Fiore

Andrew Hayes

Dimitri Tzanis

Jacek Skoczylas

Max L. Almond

John E. Mullinax

Wendy Johnston

Hayden Snow

Rick L. Haas

Dario Callegaro

Myles J. Smith

Toufik Bouhadiba

Anant Desai

Rachel Voss

Roberta Sanfilippo

Robin L. Jones

Elizabeth H. Baldini

Andrew J. Wagner

Charles N. Catton

Silvia Stacchiotti

Khin Thway

Christina L. Roland

Chandrajit P. Raut

Alessandro Gronchi

机构：

[1] City of Hope National Medical Center,Division of Surgical Oncology, Department of Surgery

[2] University of Toronto,Department of Surgical Oncology, Mount Sinai Hospital and Princess Margaret Cancer Centre, and Department of Surgery

[3] Royal Marsden Hospital,Sarcoma Unit, Department of Surgery

[4] Royal Marsden NHS Foundation Trust,Department of Surgical Oncology, Institut Curie

[5] PSL University,Department of Soft Tissue/Bone Sarcoma and Melanoma

[6] Maria Sklodowska-Curie National Research Institute of Oncology,Sarcoma Unit

[7] Queen Elizabeth Hospital,Sarcoma Department

[8] H. Lee Moffitt Cancer Center,Department of Surgery

[9] Division of Cancer Surgery,Department of Surgery, Samsung Medical Center

[10] Peter MacCallum Cancer Centre,Department of General, Visceral and Transplantation Surgery

[11] Brigham and Women’s Hospital,Department of Surgical Oncology

[12] Dana Farber Cancer Institute,Department of Surgery, The Ottawa Hospital

[13] Sungkyunkwan University School of Medicine,Division of Medical Oncology

[14] Ludwig-Maximilians-Universität Munich,Division of Surgical Oncology, Department of Surgery

[15] University Hospital,Sarcoma, Melanoma and Rare Tumors Surgery Unit

[16] The Netherlands Cancer Institute,Division of Surgical Oncology, Department of Surgery

[17] The Ottawa Hospital Research Institute,Department of Surgical Oncology

[18] University of Ottawa,Division of Melanoma, Sarcoma and Rare Tumor Surgery

[19] Candiolo Cancer Institute,Department of Surgery

[20] FPO–IRCCS,Department of Radiation Oncology

[21] Winship Cancer Institute,Department of Radiotherapy

[22] Emory University,The Institute of Cancer Research

[23] IRCCS Humanitas Research Hospital,Department of Medical Oncology

[24] The Ohio State University Comprehensive Cancer Center,Department of Cancer Medicine

[25] Fox Chase Cancer Center,Department of Medical Oncology

[26] European Institute of Oncology,Department of Radiation Oncology

[27] Fondazione IRCCS Istituto Nazionale dei Tumori,Department of Radiation Oncology, Princess Margaret Cancer Centre

[28] The Netherlands Cancer Institute,Sarcoma Unit, Department of Pathology

[29] Leiden University Medical Center,Department of Surgical Oncology

[30] Chester Beatty Laboratories,undefined

[31] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined

[32] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined

[33] Royal Marsden NHS Foundation Trust,undefined

[34] Brigham and Women’s Hospital,undefined

[35] Dana-Farber Cancer Institute,undefined

[36] Department of Medical Oncology,undefined

[37] Dana-Farber Cancer Institute,undefined

[38] University of Toronto,undefined

[39] Royal Marsden Hospital,undefined

[40] Royal Marsden NHS Foundation Trust,undefined

[41] The University of Texas MD Anderson Cancer Center,undefined

来源：

Annals of Surgical Oncology | 2022年 / 29卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：7335 / 7348

页数：13

共 257 条

[41]

Wang X(2019)Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG Clin Cancer Res. 25 2664-218

[42]

Gyorki DE(2020)Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: a study from TARPSWG Cancer. 126 4917-323

[43]

Brennan MF(2021)Recurrent retroperitoneal sarcomas: clinical outcomes of surgical treatment and prognostic factors Eur J Surg Oncol. 47 1201-7863

[44]

Chouliaras K(2021)Longitudinal prognostication in retroperitoneal sarcoma survivors: development and external validation of two dynamic nomograms Eur J Cancer. 157 291-142

[45]

Senehi R(2017)Results of resection for recurrent or residual retroperitoneal sarcoma after failed primary treatment Ann Surg Oncol. 24 211-217

[46]

Ethun CG(2019)Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients: a propensity score analysis J Surg Oncol. 119 318-1805

[47]

Tan MC(2021)Analysis of differentiation changes and outcomes at time of first recurrence of retroperitoneal liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Ann Surg Oncol. 28 7854-68

[48]

Brennan MF(2009)Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making Ann Surg. 249 137-1325

[49]

Kuk D(2014)Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery J Am Coll Surg. 218 206-2200

[50]

Tseng WW(2018)The clinical behavior of well differentiated liposarcoma can be extremely variable: a retrospective cohort study at a major sarcoma center J Surg Oncol. 117 1799-2119

← 1 2 3 4 5 6 7 8 9 10 →